| Literature DB >> 35996934 |
Ji-Hun Song1, Joonho Ahn1, Min Young Park1, Jaeyoung Park1, Yu Min Lee2, Jun-Pyo Myong1, Jung-Wan Koo1, Jongin Lee3.
Abstract
BACKGROUND: It has been 10 years since the outbreak of lung disease caused by humidifier disinfectants in Korea, but the health effects have not yet been summarized. Therefore, this study aims to systematically examine the health effects of humidifier disinfectants that have been discovered so far.Entities:
Keywords: Asthma; CMIT/MIT; Humidifier Disinfectant; PGH; PHMG; Systematic Review
Mesh:
Substances:
Year: 2022 PMID: 35996934 PMCID: PMC9424740 DOI: 10.3346/jkms.2022.37.e257
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 5.354
Fig. 1Prisma flow chart for the systematic review of humidifier disinfectant.
RISS = Research Information Sharing Service.
Definition of groups for systematic review of included studies
| Category | Definition | Number |
|---|---|---|
| Group 1 | Published original articles on human study, except reviews and brief communications | 49 |
| Group 2 | Published original articles on animal or in vitro study, except reviews and brief communications | 48 |
| Group 3 | Technical reports of temporal projects conducted by governmental agencies | 22 |
| Group 4 | Grey literatures including conference materials, thesis, dissertation, etc. | 77 |
| Total | 196 |
Published human epidemiological studies regarding humidifier disinfectant and its health effects (N = 49)
| Author/Reference | Journal | Language | Study design | Participant number | Main outcome |
|---|---|---|---|---|---|
| Kim et al. (2014) |
| English | Case-control study | Case: 18 Control: 121 | HDLI |
| Ryu et al. (2019) |
| English | Descriptive survey | 1,153 | HDLI |
| Koo et al. (2017) |
| English | Retrospective study | 59 | HDLI |
| Park et al. (2014) |
| English | Case series | 38 | Lung injury cases |
| Park et al. (2015) |
| English | Case-control study | Case: 374 Control: 303 | Exposure site |
| Lee et al. (2020) |
| Korean | Cross-sectional study | 1,555 | Exposure site |
| Hong et al. (2014) |
| English | Case series | 17 | HDLI |
| Paek et al. (2015) |
| English | Retrospective study | 374 | HDLI |
| Lee et al. (2019) |
| Korean | Descriptive survey | 4,482 | Exposure assessment methodology |
| Ryu et al. (2021) |
| English | Descriptive survey | 5,245 | Exposure assessment methodology |
| Kim et al. (2020) |
| Korean | Descriptive survey | 3,445 | Exposure assessment methodology |
| Ryu et al. (2019) |
| Korean | Descriptive survey | 5,245 | Exposure assessment methodology |
| Ju et al. (2021) |
| English | Descriptive survey | 1,413 | Non-specific death |
| Lamichhane et al. (2019) |
| English | Case-control study | Case: 244 Control: 244 | IIP |
| Kim et al. (2021) |
| English | Descriptive survey | 200 | HD effect evaluation |
| Park et al. (2020) |
| Korean | Descriptive survey | 201 | HD monitoring program |
| Yang et al. (2013) |
| English | Case-control study | Case: 16 Control: 47 | chILD |
| Lee et al. (2013) |
| English | Case series | 16 | chILD |
| Cho et al. (2017) |
| English | Cross-sectional study | 24 | Peripheral airway dysfunction |
| Kim et al. (2017) |
| English | Retrospective study | 40 | Pulmonary function in HD-exposed people |
| Cho et al. (2019) |
| English | Case-control study | Case: 81 Control: 122 | DLCO in HD-exposed people |
| Lee et al. (2018) |
| English | Case series | 2 | CMIT/MIT alone HDLI |
| Li et al. (2019) |
| English | Case report | 1 | MIT and ARDS |
| Jo et al. (2020) |
| Korean | Descriptive survey | Exposure to NaDCC | |
| Yoon et al. (2021) |
| English | Ecological study | HDLI | |
| Park et al. (2020) |
| Korean | Ecological study | HDLI (annual trends) | |
| Park et al. (2016) |
| Korean | Descriptive survey | 699 | HDLI |
| Cho (2019) |
| Korean | Cross-sectional study | 1,598 | Bronchiolitis, allergic rhinitis |
| Koh et al. (2020) |
| English | Cross-sectional study | 1,540 | Allergic rhinitis |
| Lee et al. (2021) |
| English | Cross-sectional study | 846 | Asthma |
| Leem et al. (2020) |
| English | Case series | 24 | HD-related respiratory syndrome |
| Lee et al. (2020) |
| English | Case report | 1 | Mental health |
| Kim et al. (2021) |
| English | Panel study (PSKC) | 1,113 | Neuropsychiatric outcomes |
| Ko et al. (2021) |
| English | Cross-sectional study | 456 | Psychological symptoms |
| Park et al. (2016) |
| English | Case-control study | Case: 16 Control: 60 | HDLI |
| Kang et al. (2018) |
| Korean | Descriptive survey | 42 | HD manufacturing worker |
| Park et al. (2015) |
| English | Case-control study | Case: 169 Control: 303 | HDLI |
| Park et al. (2018) |
| English | Case-control study | Case: 214 Control: 123 | HDLI |
| Nam et al. (2020) |
| English | Case report | 2 | HDLI (resolved) |
| Lim et al. (2020) |
| English | Case series | 43 | HDLI |
| Kim et al. (2014) |
| English | Descriptive survey | 138 | chILD |
| Yoon et al. (2016) |
| English | Retrospective study | 47 | chILD |
| Kim et al. (2016) |
| English | Retrospective study | 17 | chILD |
| Park et al. (2017) |
| English | Descriptive survey | 221 | HDLI |
| Yoon et al. (2017) |
| English | Descriptive survey | 1,577 | Usage rate of HD |
| Lee et al. (2019) |
| Korean | Descriptive survey | 4,030 | Usage rate of HD |
| Byeon et al. (2020) |
| Korean | Descriptive survey | 15,472 | Usage rate of HD |
| Han et al. (2020) |
| Korean | Descriptive survey | Exposure site | |
| Han et al. (2019) |
| Korean | Descriptive survey | 301 | Exposure site |
HDLI = humidifier disinfectant associated lung injury, IIP = idiopathic interstitial pneumonia, HD = humidifier disinfectant, chILD = interstitial lung disease in children, DLCO = diffusing capacity for carbon monoxide, CMIT = chloromethylisothiazolinone, MIT = methylisothiazolinone, ARDS = acute respiratory distress syndrome, NaDCC = sodium dichloroisocyanurate, PSKC = Panel Study on Korean Children.
Published toxicological animal or in-vitro studies regarding humidifier disinfectant and its health effects (N = 48)
| Author/Reference | Journal | Language | Study design | Results (keywords) |
|---|---|---|---|---|
| Song et al. (2021) |
| English | Animal study (BALB/c mice) | PHMG-P, asthma, irritant-induced airway inflammation |
| Jung et al. (2014) |
| English | In vitro study (A549 cell) | PHMG, cellular toxicity, alteration of gene expression |
| Song et al. (2014) |
| English | Animal study (C57BL/6 mice) | PHMG-P, pulmonary inflammation, fibrosis, thymic atrophy |
| Kim et al. (2017) |
| English | Animal study (SD rats) | PHMG-P, genomic changes in lungs |
| Kim et al. (2017) |
| Korean | Animal study (C57BL/6 mice) | CMIT/MIT, death, pulmonary fibrosis |
| Kang et al. (2018) |
| Korean | Animal study (ICR mice) | CMIT/MIT, stillbirth in pregnant mice |
| Do et al. (2021) |
| English | In vitro (vascular smooth muscles cells in SD rats) | CMIT/MIT, cytosolic Zn2+, ROS |
| Lee and Yu (2017) |
| English | Experimental characterization (PHMG) | Not sufficient to PHMG lung disease |
| Park et al. (2021) |
| English | Experimental characterization (PHMG) | PHMG as a polymer |
| Kim et al. (2020) |
| English | Experimental characterization (PHMG) | Hydrodynamic properties of PHMG sprayed in the air |
| Park et al. (2020) |
| English | Experimental characterization (CMIT/MIT) | CMIT/MIT varied from 12 to 353 ppm |
| Song et al. (2021) |
| English | Animal study (C57BL/6 mice) | PHMG-P not reversed even after long-term recovery |
| Park et al. (2019) |
| English | In vitro study (A549 cells) | PHMG-P, PHMB, PGH, fibrosis, EMT |
| Shin et al. (2018) |
| English | In vitro study (A549 cells) | PHMG-P-induced fibrosis |
| Jeong et al. (2019) |
| English | Animal study (C57BL/6 mice) | PHMG-P, EMT |
| Oh et al. (2018) |
| English | Animal study (Zebrafish) | PHMG-P, respiratory-specific molecular markers |
| Kim et al. (2019) |
| English | Animal study (C57BL/6 mice) | CG-745, EMT regulation |
| Seo et al. (2019) |
| English | Animal study (C57BL/6 mice) | PHMG, NADPH oxidase signaling, fibrosis |
| Kwon et al. (2021) |
| English | In vitro study (BEAS-2B cells) | CMIT/MIT, mechanical stress |
| Jeong et al. (2021) |
| English | In vitro study (HPAEpiCs) | PHMG, MT1 isomers |
| Song et al. (2020) |
| English | Animal study (C57BL/6 mice) | Kathon, fibrotic lung injury, Th2-dependent, fibrosis |
| Park and Seong (2020) |
| English | In vitro study (BEAS-2B cells) | MIT, apoptosis, MMPs |
| Park et al. (2020) |
| English | In vitro study (BEAS-2B cells) | Eosinophilia-mediated disease, pulmonary surfactants |
| Kim et al. (2016) |
| English | Animal study (SD rats) | PHMG-P, ROS, cytokines, pulmonary fibrosis |
| Song et al. (2019) |
| English | Animal study (C57BL/6 mice) | Gene expression, PHMG-P |
| Lee et al. (2020) |
| English | Animal study (Wistar rats) | Arg1, Lcn2, PHMG-P |
| Choi et al. (2022) |
| English | In vitro (BEAS-2B, A549, human H9 ES cells) | Lung fibrosis, PHMG-P, viral infection. |
| Li et al. (2021) |
| English | Animal study (C57BL/6 mice) | PHMG, pulmonary fibrosis, surfactants |
| Lim et al. (2018) |
| English | Experimental characterization (PHMG) | PHMG, hydrophilic group of lipid |
| Park et al. (2018) |
| English | In vitro study (BEAS-2B cells) | PHMG-P, apoptosis |
| Park et al. (2019) |
| English | In vitro study (A549 cells) | PHMG-P, G1/S arrest, apoptosis, ROS/ATM/p53 pathway |
| Song et al. (2018) |
| English | Animal study (C57BL/6 mice) | PHMG-P, pulmonary inflammation, fibrosis |
| Kim and Choi (2019) |
| English | Animal study (C.elegans) | CMIT/MIT, O-linked N-acetylglucosamine transferase |
| Seo and Jo (2021) |
| English | Animal study (F344 rats) | NaDCC, nasal cavity, larynx NOAEL 0.8 mg/m3 |
| Lee et al. (2021) |
| English | Animal study (BALB/c mice) | PHMG, allergic responses, CCL11, SERPINF1 |
| Go et al. (2020) |
| English | Animal study (BALB/c mice) | CMIT/MIT, Th2/Th17, atopic dermatitis |
| Shim et al. (2018) |
| English | Animal study (SD rats) | PHMG, Radioactive indium, liver |
| Kim et al. (2022) |
| English | Animal study (C57BL/6 mice) | PHMG-P, IRAK3, GSTp1, GSTp2, liver fibrosis |
| Song et al. (2020) |
| English | Animal study (Zebrafish) | PHMG-P, cardiotoxic, transcriptome changes |
| Chatterjee et al. (2021) |
| English | Animal study (Zebrafish) | CMIT/MIT, heart rates, hypermethylation, locomotion behavior |
| Cho and Kim (2020) |
| Korean | Animal study (Zebra fish) | PHMG, PGH, CMIT/MIT, dermal cell toxicity, brain toxicity |
| Lee et al. (2021) |
| English | Animal study (SD rats) | PHMG, growth retardation fetus |
| Lee et al. (2019) |
| English | Animal study (SD rats) | NOAELs of PHMG-P: 40 mg/kg/day |
| Lee and Seo (2020) |
| English | Animal study (F344 rats) | NOAEL for PHMG·HCl below 1 mg/m3 |
| Lee et al. (2022) |
| English | Animal study (SD rats) | Prenatal PHMG-P exposure offspring's future health |
| Kim and Ji (2019) |
| English | Animal study (Zebrafish) | PHMG-P, oxidative stress, thyroid hormone |
| Park et al. (2019) |
| English | In vitro study (EpiOcular) | Not meet the criteria for serious eye damage or irritation |
| Lee et al. (2021) |
| English | In vitro study (SIRC cells) | PHMG, eye, fibrosis |
PHMG(-P) = polyhexamethylene guanidine, SD = Sprague-Dawley, ICR = Institute of Cancer Research, CMIT = chloromethylisothiazolinone, MIT = methylisothiazolinone, ROS = reactive oxidative stress, PHMB = polyhexamethylene biguanide, PGH = oligo(2-(2-ethoxy)-ethoxyethyl guanidine chloride, EMT = epithelial-mesenchymal transition, MMP = matrix metalloproteinase, NaDCC = sodium dichloroisocyanurate, NOAEL = no observed adverse effect level.
Technical reports of temporal projects conducted by governmental agencies (N = 22)
| Author | Year | Classification | Agency | Study design | Main results |
|---|---|---|---|---|---|
| Kim et al. | 2016 | Relief | SICSD | Descriptive survey | Necessity of relief system |
| Leem et al. | 2017 | Relief | NIER | Report | Asthma |
| Leem et al. | 2017 | Relief | NIER | Report | Interstitial pneumonia, pneumonia, toxic hepatitis |
| Hong et al. | 2017 | Toxicology | NIER | In vitro study (serum) | Biomarkers specific to exposure |
| Yang et al. | 2017 | Relief | NIER | Report | Big data analysis from NHI, asthma |
| Park et al. | 2018 | Toxicology | SICSD | Experimental characterization (all) | Exposure doses |
| Lee et al. | 2018 | Toxicology | NIER | Animal study (Wistar rats) | Combined use of humidifier disinfectant |
| Choi et al. | 2018 | Toxicology | MOE | Animal study (SD rats) | Lung fibrosis, skin, eye irritation, CMIT/MIT |
| Kim et al. | 2018 | Epidemiology | NIER | Ecological study | Almost all respiratory diseases, NHI data, extrapulmonary diseases |
| Jeong et al. | 2019 | Toxicology | KEITI | Animal study (Wistar rats, BALB/c mice, C57BL/6 mice) | Asthma induction and exacerbation |
| Choi et al. | 2019 | Epidemiology | SICSD | Descriptive survey | Exposure in multi-use facilities |
| Lee et al. | 2019 | Relief | SICSD | Descriptive survey | Exposure in medical institutions |
| Kim et al. | 2019 | Toxicology | SICSD | Case-series (animal) | Unknown respiratory illnesses in companion animals |
| Leem et al. | 2019 | Relief | NIER | Report | HDRS, COPD, toxic hepatitis |
| Paek et al. | 2019 | Epidemiology | NIER | Report | Upper and lower respiratory diseases in CMIT/MIT alone user |
| Jeong et al. | 2019 | Epidemiology | NIER | Self-controlled case series study | Pneumonia, adult interstitial lung disease |
| Hong et al. | 2019 | Toxicology | NIER | In vitro study (serum) | Biomarkers of 26 proteins for HDLI |
| Jeong et al. | 2019 | Toxicology | MOE | Animal study (Wistar rats) | Asthma, pulmonary fibrosis, liver disease, vascular disease, eye toxicity |
| Kim | 2019 | Toxicology | NIER | Animal study (SD rats) | NaDCC, acute and subchronic respiratory effects, reversible |
| Jeong et al. | 2019 | Epidemiology | NIER | Case-control study | Asthma, incubation period of up to 10 years, COPD |
| Lee et al. | 2019 | Toxicology | KEITI | Animal study (SD rats, C57BL/6 mice) | Fetal effects of exposure during pregnancy |
| Kim et al. | 2020 | Epidemiology | SICSD | Descriptive survey | Estimation: 6.27 million users, 670,000 experienced health damage |
SICSD = Special Investigation Commission on Social Disasters, NIER = National Institute of Environmental Research, MOE = Ministry of Environment, KEITI = Korea Environmental Industry & Technology Institute, HDRS = humidifier-disinfectant related respiratory syndrome, NHI = National Health Insurance, CMIT/MIT = chloromethylisothiazolinone/methylisothiazolinone, SD = Sprague-Dawley, HDRS = Hamilton Depression Rating Scale, COPD = chronic obstructive pulmonary disease, HDLI = humidifier disinfectant associated lung injury, NaDCC = sodium dichloroisocyanurate.
Published short reports, narrative reviews, or grey literatures including conference materials, thesis, dissertation, etc. (N = 77)
| Report type | Number |
|---|---|
| Short communication | 9 |
| Thesis or dissertation | 18 |
| Conference abstract | 19 |
| Narrative review | 16 |
| Qualitative research | 2 |
| Monitoring center report | 13 |
| Total | 77 |